High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$362K
$362,615
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ONCY |
ONCOLYTICS BIOTECH INC
|
CEO
Discretionary Buy
|
2026-03-12 | $4,848 | P | Form 4 |
|
ONCY
P
ONCOLYTICS BIOTECH INC
Parsons James T.
• Director
Discretionary BuyΔOwn +31.4%
2026-03-11
$10,300
|
||||||
| ONCY |
ONCOLYTICS BIOTECH INC
|
Director
Discretionary BuyΔOwn +31.4%
|
2026-03-11 | $10,300 | P | Form 4 |
|
ONCY
P
ONCOLYTICS BIOTECH INC
Brown Deborah Margaret
• Director
Discretionary BuyΔOwn +29.5%
2026-02-12
$21,240
|
||||||
| ONCY |
ONCOLYTICS BIOTECH INC
|
Director
Discretionary BuyΔOwn +29.5%
|
2026-02-12 | $21,240 | P | Form 4 |
|
ONCY
P
ONCOLYTICS BIOTECH INC
Hagerman Allison
• Officer • VP, Product Development
Discretionary Buy
2026-02-12
$8,298
|
||||||
| ONCY |
ONCOLYTICS BIOTECH INC
|
Officer • VP, Product Development
Discretionary Buy
|
2026-02-12 | $8,298 | P | Form 4 |
|
ONCY
P
ONCOLYTICS BIOTECH INC
Heineman Thomas Charles
• Officer • Chief Medical Officer
Discretionary Buy
2026-02-12
$10,033
|
||||||
| ONCY |
ONCOLYTICS BIOTECH INC
|
Officer • Chief Medical Officer
Discretionary Buy
|
2026-02-12 | $10,033 | P | Form 4 |
| ONCY |
ONCOLYTICS BIOTECH INC
|
CEO
Discretionary BuyΔOwn +37.1%
|
2026-02-12 | $24,839 | P | Form 4 |
|
ONCY
P
ONCOLYTICS BIOTECH INC
Andrews Patricia S
• Director
Discretionary BuyΔOwn +82.8%
2026-02-12
$30,292
|
||||||
| ONCY |
ONCOLYTICS BIOTECH INC
|
Director
Discretionary BuyΔOwn +82.8%
|
2026-02-12 | $30,292 | P | Form 4 |
| ONCY |
ONCOLYTICS BIOTECH INC
|
CFO
Discretionary Buy
|
2026-02-12 | $10,104 | P | Form 4 |
| ONCY |
ONCOLYTICS BIOTECH INC
|
Director
Discretionary Buy
|
2026-02-12 | $25,338 | P | Form 4 |
| ONCY |
ONCOLYTICS BIOTECH INC
|
Director
Discretionary Buy
|
2026-02-12 | $33,864 | P | Form 4 |
|
ONCY
P
ONCOLYTICS BIOTECH INC
Seizinger Bernd R.
• Director
Discretionary BuyΔOwn +12.8%
2026-02-11
$49,590
|
||||||
| ONCY |
ONCOLYTICS BIOTECH INC
|
Director
Discretionary BuyΔOwn +12.8%
|
2026-02-11 | $49,590 | P | Form 4 |
|
ONCY
P
ONCOLYTICS BIOTECH INC
Aromando Andrew
• Officer • Chief Business Officer
Discretionary BuyΔOwn +116.1%
2026-02-11
$25,418
|
||||||
| ONCY |
ONCOLYTICS BIOTECH INC
|
Officer • Chief Business Officer
Discretionary BuyΔOwn +116.1%
|
2026-02-11 | $25,418 | P | Form 4 |
| ONCY |
ONCOLYTICS BIOTECH INC
|
CEO
Discretionary Buy
|
2026-02-11 | $4,682 | P | Form 4 |
|
ONCY
P
ONCOLYTICS BIOTECH INC
Seizinger Bernd R.
• Director
Discretionary BuyΔOwn +27.2%
2026-01-16
$103,770
|
||||||
| ONCY |
ONCOLYTICS BIOTECH INC
|
Director
Discretionary BuyΔOwn +27.2%
|
2026-01-16 | $103,770 | P | Form 4 |